GGrantIndex
← Leaderboards

Kenneth Silverman

Johns Hopkins University

$32,204,721
Attributed
$33,345,819
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$32,632,072 · 10
CDC$713,747 · 1

By mechanism

R01$33,345,819 · 11

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Randomized

Research focus

RandomizedParticipantPsychological ReinforcementPharmaceutical PreparationsBaseCocaineEmploymentWagesDrug AbstinenceAbstinenceWorkplaceEffectivenessDrug AddictionMethadoneSamplingAdultUrineUnemploymentUrinalysisAftercareEconomicsMaintenanceOpiatesBehavioral /Social Science Research Tag

Grant awards (55)

Long-Term Treatment of Opioid Use Disorder$615,882
R01 · FY2024 · DA · contact PI
Long-Term Treatment of Opioid Use Disorder$617,208
R01 · FY2023 · DA · contact PI
Long-Term Treatment of Opioid Use Disorder$682,789
R01 · FY2022 · DA · contact PI
A therapeutic workplace for homeless adults with alcohol use disorders$562,675
R01 · FY2022 · AA · contact PI
A therapeutic workplace for homeless adults with alcohol use disorders$560,288
R01 · FY2021 · AA · contact PI
Mobile technology for buprenorphine treatment engagement and overdose prevention in out-of-treatment opioid users$713,747
R01 · FY2020 · CE · contact PI
A therapeutic workplace for homeless adults with alcohol use disorders$558,547
R01 · FY2020 · AA · contact PI
Incentives for Suppression of HIV-1 RNA in People Living with HIV$743,817
R01 · FY2019 · AI · contact PI
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction$661,308
R01 · FY2019 · DA · contact PI
A therapeutic workplace for homeless adults with alcohol use disorders$554,887
R01 · FY2019 · AA · contact PI
Incentives for Suppression of HIV-1 RNA in People Living with HIV$741,994
R01 · FY2018 · AI · contact PI
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction$659,560
R01 · FY2018 · DA · contact PI
A therapeutic workplace for homeless adults with alcohol use disorders$608,475
R01 · FY2018 · AA · contact PI
Incentives for Suppression of HIV-1 RNA in People Living with HIV$740,886
R01 · FY2017 · AI · contact PI
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction$658,665
R01 · FY2017 · DA · contact PI
Incentives for Suppression of HIV-1 RNA in People Living with HIV$768,038
R01 · FY2016 · AI · contact PI
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction$650,448
R01 · FY2016 · DA · contact PI
Employment-based Depot Naltrexone Clinical Trial$608,912
R01 · FY2016 · DA · contact PI
Incentives for Suppression of HIV-1 RNA in People Living with HIV$817,836
R01 · FY2015 · AI · contact PI
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction$756,002
R01 · FY2015 · DA · contact PI
Employment-based Depot Naltrexone Clinical Trial$605,836
R01 · FY2015 · DA · contact PI
Employment-based Depot Naltrexone Clinical Trial$615,063
R01 · FY2014 · DA · contact PI
Employment-based Depot Naltrexone Clinical Trial$590,461
R01 · FY2013 · DA · contact PI
Employment-based Depot Naltrexone Clinical Trial$673,514
R01 · FY2012 · DA · contact PI
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users$639,141
R01 · FY2011 · DA · contact PI
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users$643,803
R01 · FY2010 · DA · contact PI
Employment-Based Depot Naltrexone Clinical Trial$642,025
R01 · FY2009 · DA · contact PI
Employment-Based Addiction Pharmacotherapy$638,684
R01 · FY2009 · DA · contact PI
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users$635,494
R01 · FY2009 · DA · contact PI
Employment-Based Depot Naltrexone Clinical Trial$633,533
R01 · FY2008 · DA · contact PI
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users$629,480
R01 · FY2008 · DA · contact PI
Employment-Based Addiction Pharmacotherapy$623,200
R01 · FY2008 · DA · contact PI
A Bridge to Treatment for Out-of-Treatment Injection Heroin Users$687,739
R01 · FY2007 · DA · contact PI
Employment-Based Depot Naltrexone Clinical Trial$646,663
R01 · FY2007 · DA · contact PI
Employment-Based Addiction Pharmacotherapy$620,575
R01 · FY2007 · DA · contact PI
Employment-Based Depot Naltrexone Clinical Trial$649,496
R01 · FY2006 · DA · contact PI
Employment-Based Addiction Pharmacotherapy$623,767
R01 · FY2006 · DA · contact PI
A Reinforcement-Based Therapeutic Workplace$499,740
R01 · FY2006 · DA · contact PI
Employment-Based Depot Naltrexone Clinical Trial$678,745
R01 · FY2005 · DA
Employment-Based Addiction Pharmacotherapy$623,528
R01 · FY2005 · DA
A Reinforcement-Based Therapeutic Workplace$502,364
R01 · FY2005 · DA
A THERAPEUTIC WORKPLACE FOR HOMELESS ALCOHOLICS$604,573
R01 · FY2004 · AA
A Reinforcement-Based Therapeutic Workplace$493,240
R01 · FY2004 · DA
A THERAPEUTIC WORKPLACE FOR HOMELESS ALCOHOLICS$591,379
R01 · FY2003 · AA
THERAPEUTIC WORKPLACE TO PREVENT HIV TRANSMISSION$491,192
R01 · FY2003 · DA
A Reinforcement-Based Therapeutic Workplace$484,382
R01 · FY2003 · DA
A THERAPEUTIC WORKPLACE FOR HOMELESS ALCOHOLICS$578,570
R01 · FY2002 · AA
A Reinforcement-Based Therapeutic Workplace$475,782
R01 · FY2002 · DA
THERAPEUTIC WORKPLACE TO PREVENT HIV TRANSMISSION$468,363
R01 · FY2002 · DA
A THERAPEUTIC WORKPLACE FOR HOMELESS ALCOHOLICS$565,818
R01 · FY2001 · AA
THERAPEUTIC WORKPLACE TO PREVENT HIV TRANSMISSION$457,398
R01 · FY2001 · DA
A REINFORCEMENT-BASED THERAPEUTIC WORKPLACE$365,713
R01 · FY2001 · DA
A THERAPEUTIC WORKPLACE FOR HOMELESS ALCOHOLICS$581,021
R01 · FY2000 · AA
THERAPEUTIC WORKPLACE TO PREVENT HIV TRANSMISSION$446,889
R01 · FY2000 · DA
A REINFORCEMENT-BASED THERATPEUTIC WORKPLACE$356,684
R01 · FY2000 · DA